Samuel Legeay

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Venues

Fundamental & clinical pharmacology

Nanomedicine (London, England)

Environmental science and pollution research international

International journal of molecular sciences

University of Angers

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Angers Sep 01 2017

France

Associate Professor :: Faculté de Santé - Pharmacie

Publications

Vincent Lebreton, Samuel Legeay, Clara Rapenne, Patrick Saulnier, Frédéric Lagarce
Elimination study of intact lipid nanocapsules after intravenous rat administration. Nanomedicine (London, England) (2024)
Nabil Foudi, Samuel Legeay
Effects of physical activity on cell-to-cell communication during type 2 diabetes: A focus on miRNA signaling. Fundamental & clinical pharmacology 35 (5) (2021)
Samuel Bonnet, Rana Elfatairi, Florence Franconi, Emilie Roger, Samuel Legeay
Organic nanoparticle tracking during pharmacokinetic studies. Nanomedicine (London, England) 16 (28) (2021)
Norraseth Kaeokhamloed, Emillie Roger, Jérôme Béjaud, Nolwenn Lautram, Florence Manero, Rodolphe Perrot, Chadi Abbara, Marie Briet, Samuel Legeay
New In Vitro Coculture Model for Evaluating Intestinal Absorption of Different Lipid Nanocapsules. Pharmaceutics 13 (5) (2021)
Samuel Legeay, Kien Trân, Yannick Abatuci, Sébastien Faure, Jean-Jacques Helesbeux
Novel Insights into the Mode of Action of Vasorelaxant Synthetic Polyoxygenated Chalcones. International journal of molecular sciences 21 (5) (2020)
Eid Alabed Alibrahim, Samuel Legeay, Pierre-André Billat, Emmanuelle Bichon, Ingrid Guiffard, Jean-Philippe Antignac, Pierre Legras, Jérôme Roux, Sébastien Bristeau, Nicolas Clere, Sébastien Faure, Christophe Mouvet
In vivo comparison of the proangiogenic properties of chlordecone and three of its dechlorinated derivatives formed by in situ chemical reduction. Environmental science and pollution research international 27 (33) (2019)
Samuel Legeay, Sébastien Faure
Is bisphenol A an environmental obesogen? Fundamental & clinical pharmacology 31 (6) (2017)

Samuel Legeay.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Samuel Legeay